Ocufen

   
Google
 
Web NewDrugInformation.com

Ocufen


Drug - Ocufen
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Flurbiprofen Sodium
Multiple ingredients are in alphabetical order.

Strength - 0.03%
The potency of the active ingredient(s), Flurbiprofen Sodium. May repeat for multiple part products.

Applicant - ALLERGAN
The firm name holding legal responsibility for Ocufen. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019404
The FDA assigned number to Ocufen. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ocufen. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 31, 1986
The date Ocufen was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Ocufen. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ocufen is in. Format is RX, OTC, DISCN.

Applicant Full Name - Allergan Pharmaceutical
The full name of the firm holding legal responsibility for the new application of Ocufen.

Ocufen